Access company data including market activity, funding rounds, last funding round price-per-share and valuation milestones. Use proprietary Forge Price data to track performance and monitor how company value changes over time.
Register to add companies to your watchlist and get access to bids/asks activity, last matched price and trade eligibility details.
Register| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4 |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
| Zeno Power | Energy Clean Energy | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $100.00K | -- | 1 | -- | Not available | -- | -- | $73.96M | Series B | 5/14/2025 | $45.04M | $165.6M | $1.11 | Hanaco Ventures, Seraphim Space, Balerion Space Ventures, JAWS Ventures, Vanderbilt University, RiverPark Ventures, Stage 1 Ventures, 7i Capital, Beyond Earth Ventures | |||||
| Zipwhip | Enterprise Software Communication & Collaboration Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $104.15M | Series D | 1/18/2019 | $51.5M | $255.89M | $2.95 | Goldman Sachs, OpenView, M12, Voyager Capital | |||||
| Adore Me | Consumer & Lifestyle Clothing, Fashion, Beauty & Apparel | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $54.01M | Series B | 3/14/2022 | $42.43M | $313.73M | $23.57 | Undisclosed Investors | |||||
| Aerin Medical | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $172.7M | Series G | 1/13/2025 | $32.82M | $342.42M | $1.17 | KCK MedTech, Questa Capital, OrbiMed, Ally Bridge Group, Ares Capital | |||||
| Aiolos Bio | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $247.55M | Series A | 10/24/2023 | $180M | $436.12M | $1.19 | Atlas Venture, Bain Capital Life Sciences, Forbion, Sofinnova Investments, RA Capital Management | |||||
| Allotera Therapeutics | Healthcare Other Healthcare | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $322.92M | Series C | 7/23/2026 | $83.2M | $291.45M | $1.77 | Fidelity, RiverVest Venture Partners, Lightchain Capital, LYZZ Capital, Abingworth, Intermediate Capital Group, Tybourne Capital Management, Aisling Capital Management, BioGenerator Ventures, Sands Capital, Alexandria Venture Investments, Velosity Capital, Falcon Edge Capital | |||||
| Ashvattha Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $123.69M | Series B | 1/13/2025 | $119M | $353.38M | $8.37 | Huadong Medicine, Natural Capital, Plum Alley, Tribe Capital | |||||
| Aumni | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $69.24M | Series B Voting | 8/26/2021 | $28.07M | $257.99M | $3.92 | J.P. Morgan, Pelion Venture Partners, WndrCo, Citadel Securities, Invesco Private Capital, Vanderbilt University, Kera Capital, SVB Financial Group, DLA Piper, Next Frontier Capital, Kickstart Fund, First Trust Capital Partners, Prelude, Mercato Partners fund | |||||
| Axoni | Fintech Blockchain Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $128.54M | Series BSD | 11/26/2025 | $4.5M | $218.16M | $3.22 | Undisclosed Investors | |||||
| Better Place Forests | Consumer & Lifestyle Other Consumer & Lifestyle | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $82.13M | Series 1 | 7/13/2023 | $5M | $10.85M | $0.56 | Undisclosed Investors | |||||
| BlackSwan Technologies | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $262.91M | Series B | 12/2/2022 | $79.35M | $472.32M | $79.14 | Undisclosed Investors | |||||
| Brightseed | Industrial Materials | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $242.11M | Series B | 5/9/2022 | $68M | $336.32M | $6.38 | Temasek, Lewis & Clark AgriFood, S2G Ventures, CGC Ventures, Germin8, AgFunder | |||||
| Cape Analytics | Real Estate Real Estate Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $94.34M | Series C-1 | 8/5/2022 | $15M | $340.98M | $10.81 | Undisclosed Investors | |||||
| Career Karma | Education E-Learning | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $51.98M | Series B | 1/10/2022 | $40.01M | $364.63M | $20.97 | Top Tier Capital Partners, GV, Bronze Venture Fund, Stardust, Trousdale Ventures, Alumni Ventures Group, SoftBank, Emerson Collective, Kapor Capital, Backstage, 4S Bay Partners, Y Combinator | |||||
| Chorus.ai | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $73.24M | Series C | 6/28/2020 | $33.28M | $150.41M | $3.95 | Georgian Partners, Emergence Capital, Redpoint Ventures, Sozo Ventures | |||||
| Chrome River | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $147.47M | Series D | 1/2/2018 | $135M | $327.03M | $48.96 | Great Hill Partners, First Analysis, Argentum Group, Bain Capital Ventures | |||||
| CinCor Pharma | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $192.86M | Series B | 10/12/2021 | $142.86M | $370.57M | $4.00 | General Atlantic, Perceptive Advisors, BVF Partners, venBio Partners, Adage Capital Management, Omega Funds, Rock Springs Capital, RTW Investments, Lilly Asia Ventures, Sixty Degree Capital, Sofinnova Investments, Sofinnova Partners, 5AM Ventures, CinRx | |||||
| Clumio | Enterprise Software Data Management / Storage | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $722.05M | Series D | 2/21/2024 | $75M | $151.33M | $0.74 | Sutter Hill Ventures, Index Ventures, Altimeter Capital, NewView Capital | |||||
| CommonBond | Fintech Lending | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $52.02M | Series D-1 Prime | 3/21/2018 | $3.75M | $403.8M | $3.03 | Fifth Third Capital Holdings, First Republic Bank, Columbia Seligman Investments, Neuberger Berman, August Capital, Nyca Partners, Vikram Pandit, Tom Glocer | |||||
| Disc Medicine | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $145M | Series B | 9/2/2021 | $90M | $253.72M | $2.40 | OrbiMed, Arix Bioscience, Janus Henderson Investors, 5AM Ventures, Rock Springs Capital, Nantahala Capital Management, Willett Advisors, Alexandria Venture Investments, Novo Holdings A/S, Access Biotechnology, Atlas Venture | |||||
| Dstillery | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $65.9M | Series 2A | 4/17/2026 | $8.2M | $236.6M | $1.69 | Undisclosed Investors | |||||
| Eden Health | Healthcare Healthcare Providers & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $98.78M | Series C | 2/18/2021 | $60M | $382.34M | $4.67 | Insight Partners, Amigos Health, Aspect Ventures, Company Ventures, Flare Capital, Flexcap Ventures, Max Ventures, PJC | |||||
| Emotive | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $73.9M | Series B | 2/24/2021 | $65.66M | $444.5M | $2.07 | CRV, Mucker Capital, TenOneTen Ventures, Stripes, Vulcan Capital | |||||
| Enko Chem | Industrial Other Industrial | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $150.66M | Series C | 7/27/2022 | $80M | $338.64M | $4.86 | Nufarm, Anterra Capital, Taher Gozal, Bill & Melinda Gates Foundation, Eight Roads Ventures, Finistere Ventures, Novalis LifeSciences, Germin8 Ventures, TO Ventures Food, Endeavor8, Alumni Ventures Group, Rabo Food & Agri Innovation Fund | |||||
PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES
Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
Post-Money Valuation (valuation) represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions.
Sector and subsector descriptions focus primarily on the types of companies within the respective sectors and subsectors that are typically available through Forge Markets. Any sector or subsector as a whole may include companies that participate in business lines in other sectors or subsectors. Companies are classified into sectors and subsectors according to the problem(s) they seek to solve rather than the method by which the solution is delivered.